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Resumen. Se implementó un método simple y eficiente de dos etapas 
para la síntesis de 7-cloro-4-oxo-1,4-dihidro-1,8-naftiridin-3-carboxila-
to de etilo. Comparado con la reacción de Grohe-Heitzer reportada, el 
tiempo y los pasos de reacción se redujeron empleando irradiación de 
microondas. Este compuesto es un importante intermediario para la pre-
paración de derivados de naftiridonas, los cuáles han recibido una con-
siderable atención debido a su amplio espectro de actividad biológica. 
Palabras clave: Reacción de Grohe-Heitzer; 1,8-naftiridona; irradia-
ción de microondas; equilibrio tautomérico. 
Abstract. A simple and efficient two-step method was implemented 
for the synthesis of ethyl 7-chloro-4-oxo-1,4-dihydro-1,8-naphthyri-
dine-3-carboxylate. Comparing with the reported Grohe-Heitzer reac-
tion, the time and the reaction steps have been reduced using 
microwave irradiation. This compound is an important intermediate 
for the preparation of naphthyridone derivatives which have received 
significant attention due to their broad spectrum of biological activity.
Keywords: Grohe-Heitzer reaction; 1,8-naphtyridone; microwave ir-
radiation; tautomeric equilibrium.
Introduction 
The 1,8-naphthyridone derivatives have received significant at-
tention due to their exceptionally broad spectrum of biological 
activities. The first 1,8-naphthyridone group was nalidixic acid 
used as a synthetic quinolone antibiotic [1, 2]. However, this 
quinolone showed activity only against Gram-negative micro-
organisms. Subsequent structural modifications of this quino-
lone led to a wide range of biological properties established 
them as potent scaffolds in therapeutic and medicinal research. 
The broad spectrum of activities includes antibacterial [3, 4], 
antitumor [5-9], antiviral [10, 11] and some antimycobacterial 
activities [12, 13] as well as anti-inflammatory activity [14-17]. 
The structural features of the more potent, newer generation 
quinolones such as tosufloxacin, trovafloxacin, enoxacin and 
gemifloxacin (Figure 1) include C-6 fluorine and a C-7 nitro-
gen-containing heterocycle including piperazine or pyrrolidine 
into the 1,8-naphthyridone group [3, 4, 16].
In spite of a significant number of fluoroquinolones being 
approved for treatment of bacterial infections [18]; there is still 
need for developing new derivatives that could overcome the 
emerging problem represented by bacterial chemoresistance. 
Furthermore, some antibacterial quinolones have important 
significant side effects. For example, trovafloxacin was recent-
ly removed due to its liver toxicity [19].
Numerous synthetic methods have been reported for the 
preparation of quinolones under conventional conditions; how-
ever, these methods describe long reaction times, low yields 
and elaborated work-up procedures. In this paper, we describe 
a fast microwave-assisted synthesis for the preparation of ethyl 
7-chloro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylate 
reported in the literature [5, 6, 20, 21].
Results and Discussion
The 1,8-naphthyridine ring can be prepared by two-step synthe-
sis of 3 as showed on Scheme 1. First, 2,6-dichloronicotinic 
Figure 1. Some antibacterial naphthyridones.
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acid (1) is reacted with 1,1-carbonyldiimidazol (CDI) to give an 
imidazolide intermediate at room temperature and 2-2.5 h, ac-
cording to the literature [5, 6, 21]. Which reacts with ethyl 
malonate potassium, MgCl2 and triethylamine to generate ethyl 
3-(2,6-dichloropyridin-3-yl)-3-oxopropanoate (2) using inter-
vals of room temperature to 600C and 1-15 h as reactions con-
ditions, reaching 59-93% yield. Nevertheless, these conditions 
were improved using microwave radiation, decreasing the reac-
tion time to 5 min for the synthesis of imidazolide intermediate, 
the rest of the reaction was performed according to a previous 
report described in the literature with a 93% yield.
Then, a usual route of synthesis proposes that molecule 2 
reacts with acetic anhydride and triethyl orthoformate, to gen-
erate an intermediate vinyl ether in 55 to 90% yield, using a 
nitrogen atmosphere and temperatures between 130-140 ºC. 
Following by the addition of an amine or amine substituted at 
room temperature for 1-5 h or overnight, resulting 55 to 90% 
yield. After this, the synthesized intermediate proceeds to cy-
clization reaction using 50-600C and time lapse of 1-3 h, with 
63-92% yield of compound 3. A pathway with three-step syn-
thesis that can be easily converted into one-pot synthesis. The 
molecule 2 reacts with acetic anhydride and triethyl orthofor-
mate under MW conditions (70W, 140 ºC, 3.6 min) to yield an 
intermediate vinyl ether in which CeCl3 and either NH3 or 
(NH4)2CO3 was added to produce a vinyl amine using 100W 
and 100 ºC that allowed easily undergoes cyclization at the 
same time. The crude product obtained, was purified by a sim-
ple column chromatography using hexane to obtain the 1,8-na-
phythyridone  product 3. The yields using NH3 or (NH4)2CO3 
were 73% and 75% respectively.
Compounds 2 and 3 were confirmed by 1H NMR and FT-
IR spectroscopy [19], both presented a keto-enol tautomeric 
equilibrium as shown in Scheme 2. Tautomer 2a had a CH2 
signal (4.09 ppm) while 2b gave a broad OH signal (12.54 
ppm) and a vinyl H signal (5.72 ppm). In the case of 3a, a vinyl 
H signal (8.53 ppm) and a broad NH signal (1.59 ppm) were 
observed while 3b, an OH signal (2.57 ppm) was obtained. Ac-
cording to an extensive aromatic system and intramolecular 
hydrogen bond, the enol tautomer 3b was strongly favored. 
Furthermore, the FT-IR spectra of 2 and 3 showed absorbance 
bands corresponding to the presence of O-H alcohol, C=O eno-
lic ester, as well as a C=O ester and a ketone.
Experimental
The reactions were carried out using a CEM monomode MW 
synthesizer with a CEM Discover System workstation and 
monitored by thin-layer chromatography (TLC) using silica gel 
60 F254 plates, eluting with hexane/ethylacetate. FT-IR spectra 
were obtained in KBr pellets on a Fourier Nicolet (iS10 FT-IR) 
spectrometer. NMR spectra were recorded on a Varian Mercury 
Plus 400 MHz spectrometer. Mass spectra were done on a JEOL 
MStation JMS-700 apparatus. 
Procedure and spectral data
Ethyl 3-(2,6-dichloropyridin-3-yl)-3-oxopropanoate (2a) 
and ethyl 3-(2,6-dichloropyridin-3-yl)-3-hydroxyacrylate 
(2b) 
To a solution of 2,6-dichloronicotinic acid (0.20g, 1.04 mmol) 
in THF-CH3CN (1:1, 3.0 mL) was added 1,1-carbonyldiimidaz-
ole (0.19 g, 1.17 mmol). The resulting mixture was stirred and 
heated using MW (5 Watts power at 50ºC for 5 min). This crude 
imidazolide solution was used without purification in the fol-
lowing step. To a solution of ethyl malonate potassium salt (0.19 
g, 1.09 mmol) in CH3CN (2.50 mL) was added dropwise a mix-
ture of MgCl2 (0.14 g, 1.52 mmol) and Et3N (1.50 mL) under 
ice cooling. After the mixture was stirred at room temperature 
for 5 h, the imidazolide was added. The reaction mixture was 
stirred at room temperature for 15 h, poured onto ice water (5 
mL) resulting in a pH about 11, so we acidified this mixture 
using concentrated HCl to pH = 6. The crude product was ex-
tracted with AcOEt, dried with Na2SO4 and concentrated under 
vacuum to give product 2, obtained as a yellow oil (93% yield). 
The product consisted of a mixture of the ketone 2a and the enol 
2b tautomers (confirmed by spectroscopic methods) [6]. 
IR (KBr) nmax 3133 (C-H aromatic), 2984, 2936 (C-H ali-
phatic), 1761 (C=O ester), 1736 (C=O ketone), 1631 (C=O es-
ter enolic), 1573 (C=C aromatic), 1541 (C=N aromatic), 1385 
and 1341 (C-N aromatic), 1282, 1242 and 1141 (C-O ester and 
alcohol), 1095 and 1020 (C-Cl aromatic), 843 and 772 (C-H 
Scheme 1. Microwave-assisted synthesis of ethyl 7-chloro-4-oxo-l,4-dihydro-1,8-naphthyridine-3-carboxylate.
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aromatic out of plane) cm-1. MS, m/z (%): 262.0 (M+, 21), 216 
(13), 167 (32), 149 (85), 136 (46). 
(2a) 1H NMR (CDCl3 400 MHz) δ 1.26 (t, 3 H, J = 7.20 
Hz), 4.09 (s, 2 H), 4.20 (q, 2 H, J =7.20 Hz), 7.40 (d, 1 H, J = 
8.0 Hz), 7.98 (d, 1 H, J = 8.0 Hz). 13C NMR (CDCl3 400 MHz) 
δ 192.41 (C=O ketone), 172.39 (C=O) ester, 152.93, 141.69, 
141.41, 140.85 and 123.04, (aromatic C), 60.38, 48.68 (CH2) 
and 14.01 (CH3). 
(2b) 1H NMR (CDCl3 400 MHz) δ 1.35 (t, 3 H, J = 7.20 
Hz), 4.29 (q, 2 H, J = 7.20 Hz), 5.72 (s, 1 H), 7.36 (d, 1 H, J = 
8.0 Hz), 7.94 (d, 1 H, J = 8.0 Hz), 12.54 (s, 1 H). 13C NMR 
(CDCl3 400 MHz) δ 171.16 (C=O) ester, 166.57 (C-OH alco-
hol), 152.94, 141.69, 141.41, 132.47 and 123.04 (aromatic C), 
123.46 (vinyl C), 61.78 (CH2) and 14.16 (CH3). 
Ethyl 7-chloro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-
carboxylate (3a) and ethyl 7-chloro-4-hydroxy-1,8-
naphthyridine-3-carboxylate (3b)
A mixture of 2 (0.40 g, 1.50 mmol) and acetic anhydride 
(0.36 ml, 2.25 mmol) was heated using MW at 70 Watts until 
it reached 140ºC. Then triethyl ortoformate was added 
(0.38 mL, 3.75 mmol) stirring under MW heating (70 W, 
140ºC) for 3.60 min. The reaction mixture changed from yel-
low to an intense red color. AcOEt and CH3CO2H were dis-
tilled off under reduced pressure. The resulting crude product 
was mixed with CeCl3.7H2O (5.60 mg) and stirred for 10 min. 
Then, a solution of either NH3 or (NH4)2CO3 (2.50 mmol) in 
5.10 mL of 1,4-dioxane was added in three fractions to the 
mixture under open vessel MW at 100 Watts until it reached 
100ºC for 15 min. The crude product was purified by column 
chromatography using hexane as the mobile phase to obtain 3 
as colorless solid in a mixture of ketone 3a and enol 3b tau-
tomers with m.p. 283-286ºC [20]. 73% yield was achieved by 
using NH3, while in the case of (NH4)2CO3 the yield was 75%. 
IR (KBr) nmax 3423 (O-H alcohol), 3071 (C-H aromatic), 
2986, 2926 and 2852 (C-H aliphatic), 1723 (C=O ester), 1664 
(C=O ketone), 1623 (C=O ester enolic), 1594 (C=C aromat-
ic), 1550 (C=N aromatic), 1406 (C-N amine), 1385 (C-N aro-
matic), 1289, 1219 and 1130 (C-O ester and alcohol), 1073 
and1016 (C-Cl aromatic), 796 (C-H aromatic out of plane) 
cm-1. MS, m/z (%): 222 [(M-CO-H2)+, 9], 220 (16), 167 (20), 
154 (100), 149 (79), 137 (55).
(3a) 1H NMR (CD3COCD3 400 MHz) δ 1.41 (3 H, t, J = 9 
Hz), 1.59 (1 H, bs, NH), 4.42 (2 H, q, J = 9 Hz), 7.36 (1 H, d, J 
= 10 Hz), 8.15 (1 H, d, J = 10 Hz), 8.53 (1 H, s). 13C NMR 
(CDCl3 400 MHz) δ 173.86 (C=O ketone), 164.03 (C=O ester), 
159.53, 155.80, 141.96, 123.42 and 120.56 (aromatic C), 
142.23 and 116.80 (vinyl C), 62.32 (CH2) and 14.10 (CH3). 
(3b) 1H NMR (CD3COCD3 400 MHz) δ 1.40 (3 H, t, J = 9 
Hz), 2.57 (1 H, s, OH), 4.42 (2 H, q, J = 9 Hz), 7.27 (1 H, s), 
7.46 (1 H, d, J = 10 Hz), 8.52 (1H, d, J = 10 Hz). 13C NMR 
(CDCl3 400 MHz) δ 163.46 (C=O ester), 163.08 (C-OH alco-
hol), 156.67, 154.95, 148.29, 139.06, 122.78, 111.17 and 110.92 
(aromatic C), 62.12 (CH2) and 14.15 (CH3).
Conclusion 
An improved Grohe-Heitzer methodology [21-24] was de-
veloped by the use of microwave energy reducing 2.5 h to 5 
min for the synthesis of the intermediate imidazolide. Which 
was employed in the generation of ethyl 3-(2,6-dichloro-
pyridin-3-yl)-3-oxopropanoate with 93% yield, while the 
preparation of ethyl 7-chloro-4-oxo-1,4-dihydro-1,8-naphthyri-
dine-3-carboxylate was made as one-pot reaction with 73% 
yield resulting in shorter reaction times and cleaner products. 
This useful alternative procedure could be helpful to prepare 
the skeleton of 1,8-naphthyridone agents.
Scheme 2. Tautomeric equilibrium.
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